Detalles de la búsqueda
1.
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period.
Calcif Tissue Int
; 105(3): 271-284, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31165191
2.
Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial.
J Bone Miner Res
; 34(12): 2183-2191, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31369697
3.
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.
J Bone Miner Res
; 33(8): 1383-1393, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29947083
Resultados
1 -
3
de 3
1
Próxima >
>>